Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-10-14 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +2,160 $3.95 $9K 252,605
2022-10-14 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −2,160 $39.41 $85K 250,445
2022-10-14 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −540 $39.41 $21K 190,737
2022-10-14 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Option (Right to Buy) −2,160 1,492,113
2022-10-14 Schlanger David J Executive Chairman Exercise or conversion +1,850 $0.91 $2K 84,398
2022-10-14 Schlanger David J Executive Chairman Sale −1,850 $39.41 $73K 82,548
2022-10-14 Schlanger David J Executive Chairman Exercise or conversion · Option (Right to Buy) −1,850 1,420,628
2022-10-13 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +240 $3.95 $948 250,685
2022-10-13 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −240 $39.45 $9K 250,445
2022-10-13 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −60 $39.45 $2K 191,277
2022-10-13 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Option (Right to Buy) −240 1,494,273
2022-10-13 Schlanger David J Executive Chairman Exercise or conversion +400 $0.91 $364 82,948
2022-10-13 Schlanger David J Executive Chairman Sale −400 $39.46 $16K 82,548
2022-10-13 Schlanger David J Executive Chairman Exercise or conversion · Option (Right to Buy) −400 1,422,478
2022-10-13 Payson Norman Director Sale −1,700 $36.74 $62K 343,533
2022-10-13 Payson Norman Director Sale −630 $38.33 $24K 342,903
2022-10-13 Payson Norman Director Sale −4,287 $39.00 $167K 338,616
2022-10-12 Payson Norman Director Sale −6,217 $38.35 $238K 345,633
2022-10-12 Payson Norman Director Sale −400 $38.79 $16K 345,233
2022-10-06 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +19,602 $3.95 $77K 270,047

Page 41 of 77 · 1,524 trades